We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.57B
AUM Growth
-$44M
Cap. Flow
-$44.8M
Cap. Flow %
-2.86%
Top 10 Hldgs %
22.89%
Holding
416
New
226
Increased
51
Reduced
95
Closed
41

Top Buys

Rank Stock Value
1
CIXX
CI Financial Corp.
CIXX
+$18.8M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$15.5M
3
VRTS icon
Virtus Investment Partners
VRTS
+$12.4M
4
AMZN icon
Amazon
AMZN
+$12.1M
5
MED icon
Medifast
MED
+$11.4M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$28.8M
2
VOYA icon
Voya Financial
VOYA
+$24.9M
3
ELS icon
Equity Lifestyle Properties
ELS
+$23.4M
4
BNTX icon
BioNTech
BNTX
+$16.1M
5
INDA icon
iShares MSCI India ETF
INDA
+$15.5M

Sector Composition

Rank Sector Weight
1 Healthcare 52.77%
2 Consumer Discretionary 15.05%
3 Financials 13.41%
4 Technology 7.21%
5 Industrials 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
1
UnitedHealth
UNH
$371B
$40.7M 2.6%
81,123
+13,805
+21% +$6.25M
ABT icon
2
Abbott
ABT
$188B
$40.6M 2.59%
288,654
+79,180
+38% +$10.1M
CIXX
3
DELISTED
CI Financial Corp.
CIXX
$39.7M 2.53%
1,500,000
+847,191
+130% +$18.8M
TMO icon
4
Thermo Fisher Scientific
TMO
$222B
$38.5M 2.46%
57,692
-5,528
-9% -$3.45M
IQV icon
5
IQVIA
IQV
$39.8B
$37.5M 2.39%
132,889
-15,512
-10% -$4.03M
MED icon
6
Medifast
MED
$135M
$36.6M 2.34%
175,000
+55,000
+46% +$11.4M
ABBV icon
7
AbbVie
ABBV
$438B
$32.2M 2.05%
237,484
+21,345
+10% +$2.52M
SCI icon
8
Service Corp International
SCI
$11.4B
$31.9M 2.04%
450,000
-50,000
-10% -$3.32M
AMP icon
9
Ameriprise Financial
AMP
$49.2B
$30.6M 1.95%
101,282
-877
-0.9% -$259K
BC icon
10
Brunswick
BC
$5.21B
$30.2M 1.93%
300,000
+41,620
+16% +$4.07M
GDRX icon
11
GoodRx Holdings
GDRX
$1.25B
$30M 1.91%
917,273
-91,628
-9% -$3.69M
TNDM icon
12
Tandem Diabetes Care
TNDM
$1.59B
$29.1M 1.86%
193,161
-63,695
-25% -$8.6M
LH icon
13
Labcorp
LH
$26.1B
$28.7M 1.83%
106,171
-11,628
-10% -$2.88M
AXP icon
14
American Express
AXP
$229B
$28.6M 1.83%
174,803
+3,488
+2% +$595K
PHM icon
15
Pultegroup
PHM
$24.8B
$28.6M 1.82%
500,000
+24,266
+5% +$1.24M
LHCG
16
DELISTED
LHC Group LLC
LHCG
$27.4M 1.75%
200,000
+70,000
+54% +$9.56M
LOW icon
17
Lowe's Companies
LOW
$123B
$27.3M 1.74%
105,552
-26,915
-20% -$6.4M
CHE icon
18
Chemed
CHE
$7.18B
$26.5M 1.69%
50,000
– –
SCHW
19
Charles Schwab
SCHW
$188B
$26M 1.66%
308,572
-30,437
-9% -$2.46M
THO icon
20
Thor Industries
THO
$4.14B
$25.9M 1.66%
250,000
+50,000
+25% +$5.42M
IMGN
21
DELISTED
Immunogen Inc
IMGN
$25.6M 1.63%
3,443,524
+430,057
+14% +$2.67M
KEYS icon
22
Keysight
KEYS
$57.3B
$25.5M 1.63%
123,599
-32,578
-21% -$6.09M
V icon
23
Visa
V
$675B
$25.1M 1.6%
115,971
+32
+0% +$6.87K
HOLX
24
DELISTED
Hologic
HOLX
$25M 1.6%
326,434
-77,337
-19% -$5.68M
BIIB icon
25
Biogen
BIIB
$30.6B
$24.6M 1.57%
102,484
+18,138
+22% +$4.66M
1
2 3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
NIG
NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q4 2021 Portfolio in Review

As of Q4 2021, Lombard Odier Asset Management (Switzerland) held 416 positions worth $1.57B, down 2.7% from $1.61B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lombard Odier Asset Management (Switzerland)'s Q4 2021 filing shows 226 new, 51 increased, 95 reduced and 41 closed positions. Its largest new stake was CRISPR Therapeutics: 177,769 shares worth $13.5M. The largest sale was Merck, an estimated $28.8M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Lombard Odier Asset Management (Switzerland)'s largest Q4 2021 buy was CRISPR Therapeutics: 177,769 shares worth $13.5M.
  • Lombard Odier Asset Management (Switzerland) added most to CI Financial Corp. in Q4 2021, an estimated $18.8M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q4 2021 reduction was Merck, cutting an estimated $28.8M.
  • Lombard Odier Asset Management (Switzerland) fully exited Voya Financial in Q4 2021, selling an estimated $24.9M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 23% of its $1.57B portfolio in Q4 2021.
  • Lombard Odier Asset Management (Switzerland) opened 226 new positions and closed 41 in Q4 2021.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 2.7% quarter-over-quarter to $1.57B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2021, filed 14 Feb 2022.